Trial record 13 of 219 for:
Tremor
Adaptive Portable Essential Tremor Monitor
This study has been completed.
Sponsor:
Great Lakes NeuroTechnologies Inc.
Collaborators:
Rush University Medical Center
Baylor College of Medicine
Information provided by (Responsible Party):
Great Lakes NeuroTechnologies Inc.
ClinicalTrials.gov Identifier:
NCT01602042
First received: May 16, 2012
Last updated: December 3, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the utility of a portable motion sensor-based system designed to monitor essential tremor (ET) to better prescribe therapy to minimize symptoms and expand care for ET patients.
| Condition |
|---|
|
Essential Tremor |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Phase II Study: Adaptive Portable Essential Tremor Monitor |
Resource links provided by NLM:
Genetics Home Reference related topics:
essential tremor
MedlinePlus related topics:
Tremor
U.S. FDA Resources
Further study details as provided by Great Lakes NeuroTechnologies Inc.:
Primary Outcome Measures:
- Tremor ratings during activities of daily living versus standardized tasks. [ Time Frame: 10 hours each day the sensor is worn. ] [ Designated as safety issue: No ]
| Enrollment: | 20 |
| Study Start Date: | May 2012 |
| Study Completion Date: | November 2012 |
| Primary Completion Date: | November 2012 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Essential tremor
Criteria
Inclusion Criteria:
- Aged 18 years or older
- Clinical diagnosis of essential tremor
- Able to provide informed consent
Exclusion Criteria:
- Significant medical or psychiatric illness
- Not capable of following the required clinical instructions
- Serious medical conditions that compromise safety
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01602042
Locations
| United States, Illinois | |
| Rush University Medical Center | |
| Chicago, Illinois, United States, 60612 | |
| United States, Texas | |
| Baylor College of Medicine | |
| Houston, Texas, United States, 77030 | |
Sponsors and Collaborators
Great Lakes NeuroTechnologies Inc.
Rush University Medical Center
Baylor College of Medicine
Investigators
| Principal Investigator: | Dustin A Heldman, PhD | CleveMed Inc. also dba Great Lakes NeuroTechnologies |
More Information
No publications provided
| Responsible Party: | Great Lakes NeuroTechnologies Inc. |
| ClinicalTrials.gov Identifier: | NCT01602042 History of Changes |
| Other Study ID Numbers: | 2R44AG034708-02A1 |
| Study First Received: | May 16, 2012 |
| Last Updated: | December 3, 2012 |
| Health Authority: | United States: Institutional Review Board United States: Federal Government |
Keywords provided by Great Lakes NeuroTechnologies Inc.:
|
essential tremor motion sensors tremor |
Additional relevant MeSH terms:
|
Tremor Essential Tremor Dyskinesias Neurologic Manifestations |
Nervous System Diseases Signs and Symptoms Movement Disorders Central Nervous System Diseases |
ClinicalTrials.gov processed this record on May 23, 2013